News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Dorsey Brian
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/05/2023 |
4
| Dorsey Brian (COO) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 145,000 options to buy
@ $8.42, valued at
$1.2M
|
|
| 12/09/2022 |
3
| Dorsey Brian (COO) has filed a Form 3 on ARS Pharmaceuticals, Inc. |
| 09/04/2018 |
4
| Dorsey Brian (Former SVP, Chief Dev Officer) has filed a Form 4 on APRICUS BIOSCIENCES, INC.|
Txns:
| Exercised 81,775 shares
@ $0
Paid exercise price by delivering 43,225 shares
@ $0.33, valued at
$14.3k
|
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/20/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/20/2016 |
4/A
| Dorsey Brian (SVP, Chief Development Officer) has filed a Form 4 on APRICUS BIOSCIENCES, INC. |
| 04/27/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/23/2013 |
4
| Dorsey Brian (SVP, Research) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Granted 50,000 shares
@ $0
Granted 47,654 shares
@ $0 |
|
| 04/23/2013 |
3/A
| Dorsey Brian (SVP, Research) has filed a Form 3/A on PERNIX THERAPEUTICS HOLDINGS, INC. |
| 04/23/2013 |
3
| Dorsey Brian (SVP, Research) has filed a Form 3 on PERNIX THERAPEUTICS HOLDINGS, INC. |
| 03/08/2013 |
4
| Dorsey Brian (SVP, Technical Operations) has filed a Form 4 on Pernix Sleep, Inc.|
Txns:
| Disposed/sold 28,340 shares
@ $0 |
|
| 01/03/2013 |
4
| Dorsey Brian (SVP, Technical Operations) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.|
Txns:
| Granted 1,494 shares
@ $0 |
|
| 11/20/2012 |
4
| Dorsey Brian (SVP, Technical Operations) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 shares
@ $0 |
|
| 10/02/2012 |
4
| Dorsey Brian (SVP, Technical Operations) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.|
Txns:
| Granted 15,716 shares
@ $0 |
|
| 07/03/2012 |
4
| Dorsey Brian (SVP, Technical Operations) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.|
Txns:
| Granted 15,992 shares
@ $0 |
|
| 01/04/2012 |
4
| Dorsey Brian (SVP, Technical Operations) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.|
Txns:
| Sold 9,000 shares
@ $0.4766, valued at
$4.3k
|
|
| 03/09/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/03/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/03/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/27/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/13/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/16/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/25/2010 |
4
| Dorsey Brian (SVP, Technical Operations) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.|
Txns:
| Sold 214 shares
@ $4.4829, valued at
$959.3
Sold 354 shares
@ $4.4829, valued at
$1.6k
Sold 1,412 shares
@ $4.4829, valued at
$6.3k
Sold 1,833 shares
@ $4.4829, valued at
$8.2k
Sold 1,392 shares
@ $4.4829, valued at
$6.2k
Sold 3,795 shares
@ $4.4829, valued at
$17k
Exercised 214 options to buy
@ $1.23, valued at
$263.2
Exercised 354 options to buy
@ $1.23, valued at
$435.4
Exercised 1,412 options to buy
@ $1.23, valued at
$1.7k
Exercised 1,833 options to buy
@ $1.23, valued at
$2.3k
Exercised 1,392 options to buy
@ $1.23, valued at
$1.7k
|
|
| 04/05/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/22/2010 |
4
| Dorsey Brian (VP Product Development) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 5,580 shares
@ $3.94, valued at
$22k
Sold 8,100 shares
@ $6.6135, valued at
$53.6k
Sold 2,100 shares
@ $7.8914, valued at
$16.6k
Sold 1,800 shares
@ $8.91, valued at
$16k
Sold 500 shares
@ $9.748, valued at
$4.9k
Sold 23,000 shares
@ $5.2288, valued at
$120.3k
Sold 15,800 shares
@ $6.666, valued at
$105.3k
Sold 15,900 shares
@ $7.9212, valued at
$125.9k
Sold 2,800 shares
@ $8.7843, valued at
$24.6k
Sold 500 shares
@ $9.735, valued at
$4.9k
Exercised 25,542 options to buy
@ $1.23, valued at
$31.4k
|
|
| 03/02/2010 |
4
| Dorsey Brian (VP Product Development) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.|
Txns:
| Sold 6,000 shares
@ $3.99, valued at
$23.9k
Sold 23,000 shares
@ $4.0078, valued at
$92.2k
Exercised 2,376 options to buy
@ $1.23, valued at
$2.9k
Exercised 3,624 options to buy
@ $1.23, valued at
$4.5k
Exercised 70 options to buy
@ $1.23, valued at
$86.1
Exercised 117 options to buy
@ $1.23, valued at
$143.9
Exercised 2,638 options to buy
@ $1.23, valued at
$3.2k
Exercised 12,833 options to buy
@ $1.23, valued at
$15.8k
Exercised 7,342 options to buy
@ $1.23, valued at
$9k
|
|
| 02/09/2010 |
4
| Dorsey Brian (VP Product Development) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.|
Txns:
| Sold 20,712 shares
@ $3.0595, valued at
$63.4k
Exercised 1,408 options to buy
@ $1.23, valued at
$1.7k
Exercised 2,346 options to buy
@ $1.23, valued at
$2.9k
Exercised 7,246 options to buy
@ $1.23, valued at
$8.9k
|
|
| 01/05/2010 |
4
| Dorsey Brian (VP Product Development) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.|
Txns:
| Sold 5,000 shares
@ $1.069, valued at
$5.3k
|
|
| 07/20/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
| 06/10/2009 |
4
| Dorsey Brian (VP Product Development) has filed a Form 4 on Somaxon Pharmaceuticals, Inc. |
|
|
|